Gabapentin Solution
Product Images NDC 86211-112

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 86211-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jvet Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Oral Solution 1)

A mathematical formula image showing the calculation of creatinine clearance (CLCr) based on age, weight, and serum creatinine, including an adjustment factor for female patients. This formula appears in a drug label context but is not specific to the Gabapentin product itself.*

FDA Label Image

Structure (Gabapentin Oral Solution 2)

Chemical structure of gabapentin, illustrating its cyclohexane ring bonded to amino and carboxyl functional groups.*

FDA Label Image

Diagram1 (Gabapentin Oral Solution 3)

Line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The chart has two periods: a 4-week dose titration followed by a 4-week fixed dose. Gabapentin shows a decrease in mean pain score over time, while placebo remains relatively constant.*

FDA Label Image

Diagram2 (Gabapentin Oral Solution 4)

A line graph showing mean pain scores over 7 weeks for placebo and two doses of gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents time in weeks, including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain score values.*

FDA Label Image

Diagram3 (Gabapentin Oral Solution 5)

A bar graph depicting the percentage results of two studies comparing placebo (PBO) and gabapentin (GBP) at various doses. Study 1 shows 12% for placebo versus 29% for GBP 3600 mg, while Study 2 shows 14% for placebo versus 32% and 34% for GBP 1800 mg and 2400 mg, respectively. Statistical significance is indicated for gabapentin groups.*

FDA Label Image

Diagram4 (Gabapentin Oral Solution 6)

A scatter plot comparing percentage difference versus daily dose in milligrams from three studies labeled as STUDY a, STUDY b, and STUDY c. The x-axis represents daily dose ranging from 600 to 1800 mg, and the y-axis shows percentage difference from 2% to 22%. Each study is indicated by different colored squares: black for STUDY a, gray for STUDY b, and white for STUDY c, with various values plotted for each dose.*

FDA Label Image

Label (Label)

Label for Gabapentin Oral Solution 250 mg/5 mL by JVet Pharmaceuticals LLC, distributed by JPharma. The label states prescription use only and includes directions to store refrigerated (2°C to 8°C). The package contains 16 fluid ounces (470 mL) of oral solution. The label features a barcode, NDC 86211-112-01, and instructions for the pharmacist to dispense the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.